Advanced Search

 

Study ID Status Title Patient Level Data
114203 Completed A Single Dose, Randomized, Five-Period Crossover Study to Assess the Relative Bioavailability of Four New Formulations of the CCR9 Receptor Antagonist GSK1605786A (CCX282) in Healthy Male and Female Subjects
114204 Completed A multicentre, randomized, laboratory-blinded, parallel-group study to demonstrate the efficacy and tolerability of ferrous bisglycinate chelate in iron deficiency anaemia and to compare these with those of ferrous ascorbate.
114219 Completed A multicenter, randomized, single blind, active controlled, parallel group study to determine efficacy and safety of nebulized fluticasone propionate 1mg BID compared with nebulized budesonide 2mg BID administered for 12 weeks in Chinese adult and adolescent patients with severe persistent asthma
114220 Completed A multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study to determine the efficacy and safety of nebulized fluticasone propionate 1mg twice daily compared with oral prednisone administered for 7 days to Chinese pediatric and adolescent subjects (aged 4 to 16 years) with an acute exacerbation of asthma
114236 Completed Meta Analysis Summary for Disclosure of SK&F101468 Study ROR114236: Suicidality Evaluation of Ropinirole in Restless Legs Syndrome
114237 Completed Meta-analysis of orlistat laboratory data from placebo-controlled clinical trials
114242 Active not recruiting An Open Label, Multicenter Study Investigating the Safety and Efficacy of Ofatumumab Therapy versus Physicians' Choice in Patients with Bulky Fludarabine-Refractory Chronic Lymphocytic Leukaemia (CLL)
114243 Completed GSK1550188, A randomised, single-blind, placebo controlled, dose ascending, single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic of GSK1550188 in Japanese subjects with Systemic Lupus Erythematosus (SLE) Study Listed on ClinicalStudyDataRequest.com
114246 Completed Effectiveness of belimumab treatment in a subpopulation of systemic lupus erythematosus (SLE) patients: a pooled analysis of BLISS-52 and BLISS-76
114248 Completed Immunogenicity and safety study of one dose of GSK Biologicals’ meningococcal vaccine GSK 134612 (blinded lots) versus one dose of Mencevax™ ACWY in healthy subjects aged 18-25 years Study Listed on ClinicalStudyDataRequest.com
114249 Completed Immunogenicity and safety study of one dose of GSK Biologicals’ meningococcal vaccine GSK 134612 (blinded lots) versus one dose of Menactra® in healthy subjects aged 10-25 years Study Listed on ClinicalStudyDataRequest.com
114255 Completed A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Treatment, Four 6-Week Period Cross-Over, Multi-Center Study to Evaluate the Effect of Adding GSK2190915 100mg, GSK2190915 300mg, Montelukast 10mg or Placebo Tablets Once Daily or Salmeterol 50mcg Inhalation Powder Twice Daily to Fluticasone Propionate 100mcg Inhalation Powder Twice Daily in Uncontrolled Asthmatic Subjects ≥ 12 Years of Age Study Listed on ClinicalStudyDataRequest.com
114260 Completed Immunogenicity and safety of GlaxoSmithKline Biologicals’ DTPa-IPV/Hib (Infanrix™-IPV+Hib) vaccine in healthy Korean infants
114261 Completed A Clinical Study to Evaluate Potential Biomarkers in Osteoarthritis Patients
114263 Completed A Study of the Efficacy and Safety of Multiple Doses of Dutasteride versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia Study Listed on ClinicalStudyDataRequest.com
114264 Completed Study ARI114264: A Long-Term Study of the Safety and Efficacy of Dutasteride in the Treatment of Male Subjects with Androgenetic Alopecia
114267 Active not recruiting A Phase III randomized, open-label study comparing GSK1120212 to chemotherapy in subjects with advanced or metastatic BRAF V600E/K mutation-positive melanoma
114269 Completed Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults. Study Listed on ClinicalStudyDataRequest.com
114270 Completed Immunogenicity and safety study of GSK Biologicals’ influenza vaccine Arepanrix™ (GSK2340274A) in adults 65 years of age or older Study Listed on ClinicalStudyDataRequest.com
114272 Completed A multi-center, placebo-controlled study to evaluate the safety and efficacy of GSK1278863 vs. placebo in subjects with peripheral artery disease (PAD). Study Listed on ClinicalStudyDataRequest.com
114273 Completed DCA114273: A Study Comparing Denosumab with Zoledronic Acid in Subjects of Asian Ancestry with Bone Metastases from Solid Tumors
114292 Completed A phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™/Influsplit SSW® 2010/2011 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
114294 Terminated Observer-blind Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Adjuvanted Quadrivalent Influenza Candidate Vaccines (GSK2584786A) in Children Aged 6 to 35 Months Study Listed on ClinicalStudyDataRequest.com
114296 Completed A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects with Moderate to Severe Plaque-Type Psoriasis Study Listed on ClinicalStudyDataRequest.com
114306 Completed Immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ IPV (PoliorixTM) in healthy Chinese toddlers

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.